Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients?

Title : Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients?

Source : PubMed
ID : 11053697
Authors : Walsh, C. R.; Lloyd-Jones, D. M.; Camargo, C. A. Jr; Giugliano, R. P.; O Donnell, C. J.
Year : 2000
Disease Category : Cardiovascular diseases
Focused Population : Not Specified
Priori/Posteriori : Priori
Single-study Generalibility? : Multiple
Score/Non-Score : Non-score
Tutorial/Method : NHANES_T2D
Compared general demographic and patient characteristics : Yes
Compared disease-specific clinical characteristics : No
Compared adverse events : No
Compared outcomes/treatment effect (including survival) : Yes
Eligible patients (by applying criteria) vs. ineliglble patients (by applying criteria) : Yes
Real-world data sources : Local hospital data
Target Population Data Type Levels : Hospital
Descriptive Statistics : Yes
Test characteristics between two groups? : Yes
Treatment effect : Yes
Cox proportional hazard models : Yes

Welcome to the College of Communication & Information

Schools and Colleges

Centers of Distinction

CTGATE: Clinical Trial Generalizability Assessment Toolbox

Clinical Trial Generalizability Assessment Informatics Toolbox

Title : Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients?